Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-06-03

FDA Approved: LEFLUNOMIDE — Original Application (KVK-Tech, Inc.)

View source ↗

Summary

FDA approves Leflunomide from KVK-Tech, Inc. via an Original Application (ANDA 212453). The product is indicated for rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leflunomide (Leflunomide)

Snippet

ORIG AP for LEFLUNOMIDE (LEFLUNOMIDE)